Most authors consider immunotherapy as an efficient and safe treatment for
pollen and mire allergic rhinitis.
Recent meta-analyses showed that immunotherapy brings a significant benefit
to some asthmatic patients depending on the type of allergen used, the sev
erity of the disease, the number of allergenic sensitivities. Nevertheless
everybody agrees that pharmacological treatment of asthma and immunotherapy
must be complementary when indications of desensitization are given. All p
recautions to avoid adverse systemic effects or to cure them immediately mu
st be taken. More work is needed as concerning the duration of the treatmen
t, the efficacy of some local allergen administrations, the indications in
the young child.
The future is based on the use of antigenic peptides and of recombinant all
ergens.